| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/11/2007 | CN1325043C Sweet wormwood oil drop pills and preparation method thereof |
| 07/11/2007 | CN1325042C Oral drop pills for treating bronchitis and preparation method thereof |
| 07/10/2007 | US7241882 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 07/10/2007 | US7241869 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 07/10/2007 | US7241810 For therapy of inflammatory, allergic and respiratory diseases |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241766 Methods of using phenolic guanidine sodium channel blockers |
| 07/10/2007 | US7241762 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241741 Respiratory system disorders ; concurrent administering fungicides, bactericides |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241619 Identification of genes encoding enzymes (Thraustochytrium aureum Delta 5-desaturase, Saprolegnia diclina Delta 5-desaturase, Saprolegnia diclina Delta 6-desaturase)involved in synthesis of polyunsaturated fatty acids |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2064604C Method for inhibiting pulmonary oxygen toxicity |
| 07/05/2007 | WO2007076053A2 Stable s-nitrosothiol formulations |
| 07/05/2007 | WO2007075858A2 Novel forms of tiotropium bromide and processes for preparation thereof |
| 07/05/2007 | WO2007075838A2 Pure and stable tiotropium bromide |
| 07/05/2007 | WO2007075145A1 Benzopyranone derivatives and their use as anti-coronaviral agents |
| 07/05/2007 | WO2007074859A1 Anti-c-mannosylated peptide antibody and use thereof |
| 07/05/2007 | WO2007074749A1 Prophylactic and/or therapeutic agent for chronic obstructive pulmonary disease |
| 07/05/2007 | WO2007026071A8 Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure |
| 07/05/2007 | WO2007021603A3 Methods and compositions for soothing oral and nasal tissues |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070155990 Crystalline form of beta2 adrenergic receptor agonist |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070155683 Containing a single-stranded oligonucleotide DNA molecule containing one or more CpG(s); SARS virus, hepatitis C virus, dengue virus and Japanese encephalitis, influenza virus |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154569 Use of nitrite salts for the treatment of cardiovascular conditions |
| 07/05/2007 | US20070154428 Thiazole derivative |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | DE202006008541U1 Reizlinderndes Hustenmittel Reizlinderndes cough medicine |
| 07/05/2007 | CA2635518A1 Agent for prophylactic and/or therapeutic treatment of chronic obstructive pulmonary disease |
| 07/05/2007 | CA2634250A1 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 07/05/2007 | CA2634061A1 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders |
| 07/05/2007 | CA2633353A1 Stable s-nitrosothiol formulations |
| 07/05/2007 | CA2627729A1 Novel forms of tiotropium bromide and processes for preparation thereof |
| 07/05/2007 | CA2620142A1 Pure and stable tiotropium bromide |
| 07/04/2007 | EP1803811A1 Chimeric (double) decoy |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1802612A1 Novel b1 bradykinin receptor antagonists |
| 07/04/2007 | EP1802590A1 Substituted n-alkylpyrimidinones |
| 07/04/2007 | EP1802347A1 Anti-snoring composition |
| 07/04/2007 | EP1802325A2 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 07/04/2007 | EP1802310A1 Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 07/04/2007 | EP1478741A4 Combination of a growth factor and a protease enzyme |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | EP0567566B2 Methods for treating tumor necrosis factor mediated diseases |
| 07/04/2007 | CN1993358A Thiazole derivatives as chemokine receptor antagonists |
| 07/04/2007 | CN1993336A Substituted n-acyl-2-aminothiazoles |
| 07/04/2007 | CN1993333A Triazole derivative |
| 07/04/2007 | CN1993129A Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 07/04/2007 | CN1993127A Azaindoles modulating c-kit activity and uses therefor |
| 07/04/2007 | CN1990494A Dried rehmannia root oligosaccharide and its preparation method and uses |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1990042A SARS coronary virus resistant cell vaccine and its uses |
| 07/04/2007 | CN1990037A Thymosin alpha1 active fragment and polyethylene glycol derivative thereof |
| 07/04/2007 | CN1990030A Fragrant fumigant |
| 07/04/2007 | CN1990015A Lozenge and its preparing method |
| 07/04/2007 | CN1990012A Three-yellow dispersed tablet |
| 07/04/2007 | CN1990008A Chinese medicinal preparation with heat-clearing toxin-removing function and its preparation process |
| 07/04/2007 | CN1990000A Asiatic moonseed drop pills and preparation method thereof |
| 07/04/2007 | CN1989997A Drop pill for treating pharyngitis and its preparation method |
| 07/04/2007 | CN1989987A Dripping pills of folium alstoniae scholaris and its preparation process |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/04/2007 | CN1989965A Palmatine colon positoning agent and its preparation and usage |
| 07/04/2007 | CN1989962A Capsule comprising moguisteine |
| 07/04/2007 | CN1989953A Composition of ambroxol, salt thereof and anti-infective drug |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324024C Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 07/04/2007 | CN1324014C Pyridazin-3(2h)-one derivatives as PDE4 inhibitors |
| 07/04/2007 | CN1323716C Use of SAPR-1 for the treatment and/or prevention of scleroderma |
| 07/04/2007 | CN1323715C Use of C-ski gene and its polypeptide in preparing medicine for improving tissue repairing and reducing scar formation |
| 07/04/2007 | CN1323707C Composition for treating and/or relaxing SARS and SARS kind syndrome |
| 07/04/2007 | CN1323701C Chinese medicinal composition for treating rhinitis and pharyngitis |
| 07/04/2007 | CN1323685C Application method of anastaltic Chinese medicine |
| 07/04/2007 | CN1323681C Compound preparation for upper respiratory tract infection and its use in production of medicines |
| 07/04/2007 | CN1323673C Medicinal formulation for treating upper respiratory track infection and its design method |
| 07/04/2007 | CN1323662C Pharmaceutical composition containing ambroxol and erdosteine or acetylcysteine and application thereof |
| 07/03/2007 | US7238834 Piperidine derivatives and process for their production |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238700 A2B adenosine receptor antagonists |
| 07/03/2007 | US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238675 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1 |
| 07/03/2007 | US7238664 Intratracheal or intrabronchial administration of Lusupultide and Sildenafil for treatment of COPD, bronchitis, bronchial asthma, pulmonary fibroses, emphysema, interstitial pulmonary disorders, pneumonia, ALI, ARDS and asthma bronchiale |